AMGEN PRESENTS POSITIVE PHASE 3 DATA FOR UPLIZNA® (INEBILIZUMAB-CDON) IN GENERALIZED MYASTHENIA GRAVIS (GMG) AT AANEM 2024
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Amgen Inc (NASDAQ: AMGN) | Delayed: 441.42 -5.86 (1.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $447.28 | 52 Week High | $176.85 | |||
| Open | $444.40 | 52 Week Low | $133.64 | |||
| Day High | $444.59 | P/E | 66.48 | |||
| Day Low | $440.48 | EPS | $6.64 | |||
| Volume | 268,947 | |||||
